Epigral profit and loss

Latest FY26

Revenue: ₹2,527cr−0.9% on FY25
EBITDA: ₹567cr−20.2% on FY25
Net profit: ₹332cr−7.2% on FY25
EPS: ₹76.95−9.1% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	2,626	2,527	2,550	1,929	2,188	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	10.8	15.0	15.2	6.5	8.0
	2,637	2,542	2,565	1,936	2,196
	1,603	1,491	1,322	1,072	1,212
	−99.0	−60.9	31.1	−10.8	−97.0
	136	130	114	89.7	86.6
	55.8	72.0	53.3	73.5	65.5
	170	168	133	124	109
	403	401	371	298	298
	2,269	2,200	2,025	1,645	1,674
	583	567	711	481	689
	413	399	578	358	580
Profit
	368	342	540	291	522
	368	342	540	291	522
	94.1	84.7	98.2	52.7	94.3
	2.4	−75.9	85.2	42.2	74.9
	96.5	8.8	183	94.9	169
	−0.8	−1.0	1.0	0.0	−0.0
	271	332	358	196	353
	272	333	357	196	353
	0.2	0.0	−0.4	−0.5	0.2
	271	332	357	195	354
	271	332	358	196	353
Per share
	₹62.82	₹76.95	₹84.68	₹47.13	₹85.03
	₹62.82	₹76.95	₹84.68	₹47.13	₹85.03
Other comprehensive income — detail
	0.2	0.0	−0.4	—	—
	0.2	0.0	−0.7	−0.7	0.3
	0.1	0.0	−0.2	—	—
	—	—	—	−0.3	0.1
	271	332	357	195	354
Per share — as-filed variants
	₹62.82	₹76.95	₹84.68	₹47.13	₹85.03
	₹62.82	₹76.95	₹84.68	₹47.13	₹85.03
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	1,122	1,097	1,197	868	1,074
	42.7%	43.4%	46.9%	45.0%	49.1%
Adjusted (ex-exceptional items) — derived
	368	342	540	291	522
	271	332	358	196	353
	₹62.82	₹76.95	₹84.68	₹47.13	₹85.03

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

EPIGRAL₹907.30

Epigral Limited

· Chemicals

Annual Quarterly₹ CrorePeersYASHO GUJALKALI FCL FOSECOIND VISHNU TATVA GALAXYSURF JUBLCPLMcap ₹3,914 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	2,188.4	1,929.2	2,550.1	2,527.2	2,626.0
Other Income	8.0	6.5	15.2	15.0	10.8
Total Income	2,196.4	1,935.7	2,565.3	2,542.2	2,636.8
Expenses
+ Cost of Materials Consumed	1,211.8	1,071.6	1,322.4	1,490.7	1,602.7
+ Changes in Inventories	-97.0	-10.8	31.1	-60.9	-99.0
+ Employee Benefit Expense	86.6	89.7	114.5	129.7	136.3
+ Finance Costs	65.5	73.5	53.3	72.0	55.8
+ Depreciation & Amortisation	109.0	123.6	132.6	168.3	169.7
+ Other Expenses	298.1	297.5	371.4	400.7	403.1
Total Expenses	1,673.9	1,645.0	2,025.2	2,200.4	2,268.6
EBITDA	688.9	481.2	710.7	567.1	582.9
EBIT	580.0	357.6	578.2	398.8	413.2
Profit
PBT before Exceptional Items	522.5	290.7	540.1	341.8	368.3
Pretax Income	522.5	290.7	540.1	341.8	368.3
+ Current Tax	94.3	52.7	98.2	84.7	94.1
+ Deferred Tax	74.9	42.2	85.2	-75.9	2.4
Tax Expense	169.2	94.9	183.4	8.8	96.5
+ Share of Associates & JVs	-0.0	0.0	1.0	-1.0	-0.8
Net Income	353.3	195.8	357.7	332.0	271.0
+ Net Income — Continuing Ops	353.3	195.8	356.7	333.0	271.8
+ Other Comprehensive Income	0.2	-0.5	-0.4	0.0	0.2
Total Comprehensive Income	353.5	195.3	357.3	332.0	271.2
Net Income to Common	353.3	195.8	357.7	332.0	271.0
Per Share
Basic EPS	85.03	47.13	84.68	76.95	62.82
Diluted EPS	85.03	47.13	84.68	76.95	62.82
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.4	0.0	0.2
+ Items NOT to be Reclassified to P&L	0.3	-0.7	-0.7	0.0	0.2
+ Tax on Items NOT to be Reclassified	—	—	-0.2	0.0	0.1
+ Tax on Items NOT to be Reclassified — alt tag	0.1	-0.3	—	—	—
Comprehensive Income — Owners of Parent	353.5	195.3	357.3	332.0	271.2
Per Share — as-filed variants
Basic EPS — Continuing Operations	85.03	47.13	84.68	76.95	62.82
Diluted EPS — Continuing Operations	85.03	47.13	84.68	76.95	62.82
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	1,073.6	868.4	1,196.6	1,097.5	1,122.3
Gross Margin %	49.06	45.01	46.92	43.43	42.74
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	522.5	290.7	540.1	341.8	368.3
Net Income Adj (tax-effected)	353.3	195.8	357.7	332.0	271.0
EPS Adj	85.03	47.13	84.68	76.95	62.82
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	41.6	41.6	43.1	43.1	43.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.